📰 Concept Trial News
Concept Trial News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Concept Trial. Real-time updates on events, politics, business and more.
August 10, 2023
NDA submission for etripamil in patients with PSVT expected in October 2023Data featured during oral session at Heart Rhythm 2023 Annual Meeting support the potential of etripamil in patients with... -Today at 07:37 am- MarketScreener
June 5, 2023
Astria Therapeutics, Inc. , a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and... | June 5, 2023
May 11, 2023
- NDA submission for etripamil in patients with PSVT currently on track for 3Q23 - Company to host virtual KOL event focused on etripamil for the potential treatment of AFib-RVR on... | May 11, 2023
April 28, 2023
Astria Therapeutics, Inc. , a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and... | April 28, 2023
May 12, 2022
/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...
March 24, 2022
/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...
February 24, 2021
/PRNewswire/ -- SSOGEN Corporation, a Gold level member of Oracle Partner Network, today announced it implemented an SSO security upgrade solution to assist a...